Characterization of novel antibodies for understanding MUC16 cleavage and its pathological implications in cancer

被引:0
|
作者
Aithal, Abhijit
Junker, Wade
Kaur, Sukhwinder
Das, Srustidhar
Kshirsagar, Prakash
Rachagani, Satyanarayana
Mallya, Kavita
Jain, Maneesh
Batra, Surinder K.
机构
关键词
D O I
10.1158/1538-7445.AM2016-2978
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2978
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer
    Aithal, Abhijit
    Junker, Wade M.
    Kshirsagar, Prakash
    Das, Srustidhar
    Kaur, Sukhwinder
    Orzechowski, Catherine
    Gautam, Shailendra Kumar
    Jahan, Rahat
    Sheinin, Yuri M.
    Lakshmanan, Imayavaramban
    Ponnusamy, Moorthy P.
    Batra, Surinder K.
    Jain, Maneesh
    PLOS ONE, 2018, 13 (04):
  • [2] MUC16 as a novel target for cancer therapy
    Aithal, Abhijit
    Rauth, Sanchita
    Kshirsagar, Prakash
    Shah, Ashu
    Lakshmanan, Imayavaramban
    Junker, Wade M.
    Jain, Maneesh
    Ponnusamy, Moorthy P.
    Batra, Surinder K.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2018, 22 (08) : 675 - 686
  • [3] Pathobiological Implications of MUC16 Expression in Pancreatic Cancer
    Haridas, Dhanya
    Chakraborty, Subhankar
    Ponnusamy, Moorthy P.
    Lakshmanan, Imayavaramban
    Rachagani, Satyanarayana
    Cruz, Eric
    Kumar, Sushil
    Das, Srustidhar
    Lele, Subodh M.
    Anderson, Judy M.
    Wittel, Uwe A.
    Hollingsworth, Michael A.
    Batra, Surinder K.
    PLOS ONE, 2011, 6 (10):
  • [4] Understanding the Role of Cancer Glycosylation on Antibody Binding to MUC16
    Karnwal, Saloni
    Brooks, Teresa
    Patterson, Michelle
    Brooks, Cory L.
    FASEB JOURNAL, 2022, 36
  • [5] MUC16: molecular analysis and its functional implications in benign and malignant conditions
    Haridas, Dhanya
    Ponnusamy, Moorthy P.
    Chugh, Seema
    Lakshmanan, Imayavaramban
    Seshacharyulu, Parthasarathy
    Batra, Surinder K.
    FASEB JOURNAL, 2014, 28 (10): : 4183 - 4199
  • [6] Novel Monoclonal Antibodies Against the Proximal (Carboxy-Terminal) Portions of MUC16
    Rao, Thapi Dharma
    Park, Kay J.
    Smith-Jones, Peter
    Iasonos, Alexia
    Linkov, Irina
    Soslow, Robert A.
    Spriggs, David R.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2010, 18 (05) : 462 - 472
  • [7] Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth
    Rao, Thapi Dharma
    Fernandez-Tejada, Alberto
    Axelrod, Abram
    Rosales, Nestor
    Yan, Xiujun
    Thapi, Sahityasri
    Wang, Amy
    Park, Kay J.
    Nemieboka, Brandon
    Xiang, Jingyi
    Lewis, Jason S.
    Olvera, Narciso
    Levine, Douglas A.
    Danishefsky, Samuel J.
    Spriggs, David R.
    ACS CHEMICAL BIOLOGY, 2017, 12 (08) : 2085 - 2096
  • [8] Understanding the Unique Attributes of MUC16 (CA125): Potential Implications in Targeted Therapy
    Das, Srustidhar
    Batra, Surinder K.
    CANCER RESEARCH, 2015, 75 (22) : 4669 - 4674
  • [9] Study of MUC16/ERBB axis in pancreatic cancer
    Baniya, Amina
    Hollingsworth, Michael A.
    CANCER RESEARCH, 2024, 84 (02)
  • [10] MUC16 Targeted Antibodies for PET Imaging of Epithelial Ovarian Carcinoma
    Nemieboka, Brandon
    Thapi, Dharmarao
    Bitton, Ariana
    Lewis, Jason
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57